160 related articles for article (PubMed ID: 38771467)
21. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
[TBL] [Abstract][Full Text] [Related]
22. [Eosinophilic colitis. A report of two cases with non conventional treatment].
Rosas Vargas MA; Moncayo Coello V; García Cárdenas E; Valencia Mayoral P; Sienra Monge JJ; del Río Navarro BE
Rev Alerg Mex; 2004; 51(6):231-5. PubMed ID: 15794416
[TBL] [Abstract][Full Text] [Related]
23. Ketotifen: a new drug for prophylaxis of asthma in children.
Simons FE; Luciuk GH; Becker AB; Gillespie CA
Ann Allergy; 1982 Mar; 48(3):145-50. PubMed ID: 6121527
[TBL] [Abstract][Full Text] [Related]
24. Ketotifen in atopic asthma and exercise-induced asthma.
Petheram IS; Moxham J; Bierman CW; McAllen M; Spiro SG
Thorax; 1981 Apr; 36(4):308-12. PubMed ID: 6116296
[TBL] [Abstract][Full Text] [Related]
25. Wheat Sensitivity and Functional Dyspepsia: A Pilot, Double-Blind, Randomized, Placebo-Controlled Dietary Crossover Trial with Novel Challenge Protocol.
Potter MDE; Duncanson K; Jones MP; Walker MM; Keely S; Talley NJ
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629906
[No Abstract] [Full Text] [Related]
26. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.
Serna H; Porras M; Vergara P
J Pharmacol Exp Ther; 2006 Dec; 319(3):1104-11. PubMed ID: 16988056
[TBL] [Abstract][Full Text] [Related]
27. Ketotifen in prevention of indomethacin-induced gastropathy.
Narendranathan M; Chitra P; Kurien M; Philip J
Indian J Gastroenterol; 1999; 18(2):76-7. PubMed ID: 10319538
[TBL] [Abstract][Full Text] [Related]
28. Benefit of ketotifen in patients with eosinophilic gastroenteritis.
Melamed I; Feanny SJ; Sherman PM; Roifman CM
Am J Med; 1991 Mar; 90(3):310-4. PubMed ID: 2003512
[TBL] [Abstract][Full Text] [Related]
29. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
[TBL] [Abstract][Full Text] [Related]
30. [Effect of electroacupuncture at "Zusanli" (ST 36) on duodenal mast cells, NGF and NTRK1 in rats with functional dyspepsia].
Dong JZ; Rong PJ; Wang XT; Wang D; Leng MH; Xiao LJ
Zhongguo Zhen Jiu; 2022 Jul; 42(7):767-72. PubMed ID: 35793886
[TBL] [Abstract][Full Text] [Related]
31. Ketotifen--a therapeutic agent of eosinophilic fasciitis?
Ching DW; Leibowitz MR
J Intern Med; 1992 May; 231(5):555-9. PubMed ID: 1602294
[TBL] [Abstract][Full Text] [Related]
32. Resolution of eosinophilic peritonitis with ketotifen.
Tang S; Lo CY; Lo WK; Chan TM
Am J Kidney Dis; 1997 Sep; 30(3):433-6. PubMed ID: 9292574
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.
Greiner JV; Mundorf T; Dubiner H; Lonsdale J; Casey R; Parver L; Kapik BM; Shams NB; Abelson MB
Am J Ophthalmol; 2003 Dec; 136(6):1097-105. PubMed ID: 14644221
[TBL] [Abstract][Full Text] [Related]
34. A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%.
Artal MN; Luna JD; Discepola M
Acta Ophthalmol Scand Suppl; 2000; (230):64-5. PubMed ID: 11057355
[TBL] [Abstract][Full Text] [Related]
35. Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial.
Katayose Y; Aritake S; Kitamura S; Enomoto M; Hida A; Takahashi K; Mishima K
Hum Psychopharmacol; 2012 Jul; 27(4):428-36. PubMed ID: 22806823
[TBL] [Abstract][Full Text] [Related]
36. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching.
Riccardi VM
Arch Dermatol; 1993 May; 129(5):577-81. PubMed ID: 8481017
[TBL] [Abstract][Full Text] [Related]
37. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
[TBL] [Abstract][Full Text] [Related]
38. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Ueno M; Inagaki N; Nagai H; Koda A
Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
[TBL] [Abstract][Full Text] [Related]
39. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
[TBL] [Abstract][Full Text] [Related]
40. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
